Physician

Nicolas Jano Mouawad

According to 2025 Medicare claims, Nicolas Mouawad (NPI: 1730388497) practices vascular surgery in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. This provider's primary affiliated billing organization is MCLAREN BAY REGION (NPI: 1508131087; TIN: 381976271) and primary practice location at 48708-6831. Mouawad is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Mouawad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 962 traditional Medicare patients, billed 3,075 HCPCS/CPT codes, and received $253,753 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 232 prescription claims across 101 beneficiaries totaling $39,136 in drug costs, led by Xarelto (Rivaroxaban). 2017 DME data shows 42 claims. Open Payments data shows 441 records totaling $490,481. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,225 to $39,136. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,051	2,610	$254,997
2016	1,195	2,900	$261,630
2017	1,487	3,933	$380,408
2018	1,596	4,459	$412,730
2019	1,558	3,947	$358,826
2020	929	2,391	$229,266
2021	933	2,120	$206,744
2022	1,082	2,897	$244,338
2023	1,100	3,118	$242,746
2024	962	3,075	$253,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	87	212	$5,225
2016	105	328	$18,357
2017	140	453	$16,474
2018	160	528	$24,054
2019	189	576	$33,709
2020	186	543	$53,618
2021	124	352	$31,777
2022	125	323	$44,014
2023	121	256	$62,932
2024	101	232	$39,136

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	30	42	$27,540
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	97	104	$106
93880	Ultrasound of both sides of head and neck blood flow	353	372	$30
93970	Ultrasound study of arm or leg veins with compression and maneuvers	96	98	$26
76937	Ultrasonic guidance for blood vessel access	124	192	$11
93922	Ultrasound study of arm and leg arteries	127	145	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	16	1,320	$25,539
Clopidogrel	Clopidogrel Bisulfate	131	10,497	$2,301
Cilostazol	Cilostazol	34	2,760	$1,165
Atorvastatin Calcium	Atorvastatin Calcium	21	1,830	$228

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	327	$310,953	Inari Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	113	$179,527	Inari Medical, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$13,087	CENTERLINE BIOMEDICAL INC.

Explore More Providers

FAQ

What Medicare data is available for Nicolas Jano Mouawad?

Tedicare shows public-source Medicare data for Nicolas Jano Mouawad (NPI 1730388497), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicolas Jano Mouawad have ACO affiliation data?

Nicolas Jano Mouawad is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Nicolas Jano Mouawad?

Nicolas Jano Mouawad is linked to MCLAREN BAY REGION (billing NPI 1508131087) in the available physician profile data.

Does Nicolas Jano Mouawad have Open Payments data?

Nicolas Jano Mouawad has 441 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.